Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281738553> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4281738553 endingPage "e22016" @default.
- W4281738553 startingPage "e22016" @default.
- W4281738553 abstract "e22016 Background: Optic pathway gliomas (OPG) constitute 1-5% of childhood brain tumors. The presence of neurofibromatosis type 1 (NF-1) is generally associated with more indolent disease. The aim of this study is to evaluate patients with optic pathway gliomas diagnosed/treated/ followed in a single center over 32 years. Methods: The medical files of 85 patients with OPG diagnosed/treated between 1990-2021 in the Istanbul University, Oncology Institute were retrospectively assessed for demographic, clinical characteristics, treatment and outcome. Results: The median age of the 85 patients (42 male, 43 female) was 60 (1-216) months, 53 (62.4%) had NF-1. Seven had diencephalic syndrome (8.2%). According to Dodge classification, 23 (27.1%) had Dodge 1, 30 (35.3%) Dodge 2 and 32 (37.6%) Dodge 3 disease. Median follow up time was 10.5 years (1-31 years). Twenty (23.5%) patients had stable disease and were followed without treatment, 14 patients underwent surgery (5 gross total tumor resection, 2 subtotal resection, 3 ventriculoperitoneal shunt operation, 4 excision/biopsy). 7 patients recieved radiotherapy (RT), none had NF1. 56 patients received chemotherapy (CT) due to severe/progressive clinical symptoms (such as diencephalic syndrome, visual impairment, nystagmus) or radiologic progressive disease. Chemotherapy consisted of an adapted SIOP-LGG regimen: vincristine (VCR) 1.5 mg/m²/dose and carboplatinum 550 mg/m²/dose every 21 days for three courses with weekly VCR, followed by VCR and carboplatinum every 28 days for a total of 12 cycles (3 cycles induction, 9 cycles consolidation). Vinblastin or cisplatinum with etoposide were used for second line or further treatment in progressive disease. One of the seven patients who had diencephalic syndrome and two of the 3 patients with leptomeningeal metastasis died. Ocular findings were recorded in 47 patients: vision was stable in 30 (63.8%), improved in 15 (31.9%), detoriated in 2 (4.3%). Radiology (MRI) revealed stable disease/regression of tumor in 41 patients, and complete regression of spinal metastasis in 1 patient. Endocrinologic follow-up was done and 13(15.2%) recieved hormonal treatment. Ten year overall survival(S) in all patients, in patients with NF1 and without NF1 were 96.5%, 96.1% and 95%, respectively; 10 year event free survival (EFS) in all patients, in patients with NF1 and without NF1 were 80.6%, 90.5% and 60% (p:0.001) respectively. Conclusions: OPG may remain indolent for many years after diagnosis, especially in patients with NF 1. However, these tumors develop progressive characteristics and can cause visual disturbances, endocrine dysfunction, blindness and even death among some of the patients. In young children who are symptomatic/have progressive disease, chemotherapy with an adapted regimen consisting of vincristine and carboplatinum seems to be effective and provides a relatively good quality of life." @default.
- W4281738553 created "2022-06-13" @default.
- W4281738553 creator A5020511059 @default.
- W4281738553 creator A5028631402 @default.
- W4281738553 creator A5036490891 @default.
- W4281738553 creator A5077866054 @default.
- W4281738553 date "2022-06-01" @default.
- W4281738553 modified "2023-10-16" @default.
- W4281738553 title "Optic pathway gliomas in children: Demographic, clinical characteristics, and results of an adapted protocol." @default.
- W4281738553 doi "https://doi.org/10.1200/jco.2022.40.16_suppl.e22016" @default.
- W4281738553 hasPublicationYear "2022" @default.
- W4281738553 type Work @default.
- W4281738553 citedByCount "0" @default.
- W4281738553 crossrefType "journal-article" @default.
- W4281738553 hasAuthorship W4281738553A5020511059 @default.
- W4281738553 hasAuthorship W4281738553A5028631402 @default.
- W4281738553 hasAuthorship W4281738553A5036490891 @default.
- W4281738553 hasAuthorship W4281738553A5077866054 @default.
- W4281738553 hasConcept C126838900 @default.
- W4281738553 hasConcept C141071460 @default.
- W4281738553 hasConcept C2776694085 @default.
- W4281738553 hasConcept C2776755627 @default.
- W4281738553 hasConcept C2778336483 @default.
- W4281738553 hasConcept C2778822529 @default.
- W4281738553 hasConcept C2778984943 @default.
- W4281738553 hasConcept C2779429289 @default.
- W4281738553 hasConcept C2780103909 @default.
- W4281738553 hasConcept C2781413609 @default.
- W4281738553 hasConcept C509974204 @default.
- W4281738553 hasConcept C71924100 @default.
- W4281738553 hasConceptScore W4281738553C126838900 @default.
- W4281738553 hasConceptScore W4281738553C141071460 @default.
- W4281738553 hasConceptScore W4281738553C2776694085 @default.
- W4281738553 hasConceptScore W4281738553C2776755627 @default.
- W4281738553 hasConceptScore W4281738553C2778336483 @default.
- W4281738553 hasConceptScore W4281738553C2778822529 @default.
- W4281738553 hasConceptScore W4281738553C2778984943 @default.
- W4281738553 hasConceptScore W4281738553C2779429289 @default.
- W4281738553 hasConceptScore W4281738553C2780103909 @default.
- W4281738553 hasConceptScore W4281738553C2781413609 @default.
- W4281738553 hasConceptScore W4281738553C509974204 @default.
- W4281738553 hasConceptScore W4281738553C71924100 @default.
- W4281738553 hasIssue "16_suppl" @default.
- W4281738553 hasLocation W42817385531 @default.
- W4281738553 hasOpenAccess W4281738553 @default.
- W4281738553 hasPrimaryLocation W42817385531 @default.
- W4281738553 hasRelatedWork W1568769885 @default.
- W4281738553 hasRelatedWork W1998725282 @default.
- W4281738553 hasRelatedWork W2016341751 @default.
- W4281738553 hasRelatedWork W2052617720 @default.
- W4281738553 hasRelatedWork W2077242620 @default.
- W4281738553 hasRelatedWork W2121694206 @default.
- W4281738553 hasRelatedWork W2346904363 @default.
- W4281738553 hasRelatedWork W2403331838 @default.
- W4281738553 hasRelatedWork W2410654427 @default.
- W4281738553 hasRelatedWork W4281738553 @default.
- W4281738553 hasVolume "40" @default.
- W4281738553 isParatext "false" @default.
- W4281738553 isRetracted "false" @default.
- W4281738553 workType "article" @default.